Radioembolization with 90Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors

Annals of Nuclear Medicine

Volumn 30, Issue 1, 2016, Pages 29-34

  Soydal, Cigdem ^a   Kucuk, Ozlem Nuriye ^a   Bilgic, Sadik ^a   Ibis, Erkan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Intrahepatic cholangiocellular carcinoma; Overall survival; Radioembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FLUORODEOXYGLUCOSE F 18; MICROSPHERE; RESIN; YTTRIUM 90; YTTRIUM;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER INJURY; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; OVERALL SURVIVAL; PET-CT SCANNER; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR VOLUME; AGED; ARTIFICIAL EMBOLIZATION; BILE DUCT NEOPLASMS; CHEMISTRY; CHOLANGIOCARCINOMA; DIAGNOSTIC IMAGING; PROGNOSIS; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADULT; AGED; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MALE; MICROSPHERES; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT; YTTRIUM RADIOISOTOPES;

EID: 84953838502     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-015-1026-y     Document Type: Article

References (17)

1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–25.
2. Altaee MY, Johnson PJ, Farrant JM, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer. 1991; 68:2051–5.
3. Yi B, Zhang BH, Zhang YJ, Jiang XQ, Zhang BH, Yu WL, et al. Surgical procedure and prognosis of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2004;3:453–7.
4. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806–13.
5. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.
6. Mazhar D, Stebbing J, Bower M. Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol. 2006;2:509–14.
7. Cianni R, Urigo C, Notarianni E, Saltarelli A, D’Agostini A, Iozzino M, et al. Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases. Radiol Med. 2010;115:619–33.
8. Padia SA, Kwan SW, Roudsari B, Monsky WL, Coveler A, Harris WP. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity. J Vasc Interv Radiol. 2014;25:1067–73.
9. Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy, and survival. Radiology. 2008;247:507–15.
10. Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24:1227–34.
11. Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008;113:2119–28.
12. Kao YH, Tan EH, Ng CE, Goh SW. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann Nucl Med. 2011;25:455–61.
13. Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol. 2012;35:105–16.
14. Filippi L, Pelle G, Cianni R, Scopinaro F, Bagni O. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma. Nucl Med Biol. 2015;42:59–64.
15. Kucuk ON, Soydal C, Araz M, Bilgic S, Ibis E. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT. Clin Nucl Med. 2013;38:283–9.
16. Soydal C, Kucuk ON, Gecim EI, Bilgic S, Elhan AH. The prognosticvalue of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer. Nucl Med Commun. 2013;34:501–6.
17. Gulec SA, Suthar RR, Barot TC, Pennington K. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy. Eur J Nucl Med Mol Imaging. 2011;38:1289–95.